Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

This study has been terminated.
(lack of accrual)
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT00053833
First received: February 5, 2003
Last updated: November 7, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2004
  Primary Completion Date: July 2004 (Final data collection date for primary outcome measure)